This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Advance Trade in Goods Came in Less Low Than Expected
by Zacks Equity Research
Advance Trade in Goods Came in Less Low Than Expected
Walgreens (WBA) Beats, Pre-Markets Muted
by Mark Vickery
WBA shares are up +1% on the earnings report; however, the stock remains more than -10% year to date.
Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 5.45% and 4.16%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots (WBA) Benefits From Innovation Amid Margin Woe
by Zacks Equity Research
Walgreens Boots' (WBA) comparable pharmacy sales decline reflects lower demand for COVID-19 services.
What to Expect From BlackBerry's (BB) Q4 Earnings Release
by Zacks Equity Research
BlackBerry's (BB) fourth-quarter fiscal 2023 revenues are likely to have affected by lower revenues from Cybersecurity business segment.
The Zacks Analyst Blog Highlights Valero Energy, Roper Technologies, American Electric Power, CrowdStrike Holdings and Walgreens Boots Alliance
by Zacks Equity Research
Valero Energy, Roper Technologies, American Electric Power, CrowdStrike Holdings and Walgreens Boots Alliance are included in this Analyst Blog.
Top Research Reports for Valero Energy, Roper Technologies & American Electric Power
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Valero Energy Corporation (VLO), Roper Technologies, Inc. (ROP) and American Electric Power Company, Inc. (AEP).
CalMaine Foods (CALM) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CalMaine Foods' (CALM) third-quarter 2023 results are likely to reflect higher average selling prices for conventional eggs, improved volumes and savings from its cost-control actions.
Is a Surprise Coming for Walgreens Boots Alliance (WBA) This Earnings Season?
by Zacks Equity Research
Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $33.54, moving +1.05% from the previous trading session.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens (WBA) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Walgreens' (WBA) strategic executions on the United States and the international front is likely to have contributed to the Q2 2023 top line.
Is Trending Stock Walgreens Boots Alliance, Inc. (WBA) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Here's Why You Should Retain Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA), backed by continued partnership growth and a strong focus on strategic execution.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $33.29 in the latest trading session, marking a -0.83% move from the prior day.
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SDY
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Walgreens (WBA). This makes it worthwhile to examine what the stock has in store.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $35.45 in the latest trading session, marking a -1.77% move from the prior day.
Walgreens Boots (WBA) Benefits From New Launches Amid FX Woes
by Zacks Equity Research
Walgreens Boots' (WBA) comparable pharmacy sales decline, reflecting lower demand for COVID-19 services.
Will Walgreens (WBA) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Walgreens (WBA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Excellent ETFs for Your IRA
by Neena Mishra
We highlight 3 high-dividend ETFs that focus on sustainability of dividends
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $35.39 in the latest trading session, marking a -1.15% move from the prior day.
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDIV
Walgreens' (WBA) New Partnerships Aid, Margin Pressure Ails
by Zacks Equity Research
Walgreens Boots (WBA) raises its U.S. Healthcare target, including fiscal 2025 sales goal.